Ekso Bionics (EKSO) Set to Announce Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) will be issuing its quarterly earnings data after the market closes on Monday, April 29th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Ekso Bionics (NASDAQ:EKSO) last released its quarterly earnings results on Monday, March 4th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.11). Ekso Bionics had a negative net margin of 83.14% and a negative return on equity of 90.80%. The business had revenue of $4.85 million for the quarter, compared to analyst estimates of $4.80 million. During the same period in the prior year, the business earned ($0.24) earnings per share. On average, analysts expect Ekso Bionics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ekso Bionics Trading Down 2.3 %

EKSO stock opened at $1.25 on Friday. The business has a fifty day moving average price of $1.52 and a 200 day moving average price of $1.61. Ekso Bionics has a fifty-two week low of $0.62 and a fifty-two week high of $3.13. The stock has a market capitalization of $22.38 million, a price-to-earnings ratio of -1.14 and a beta of 1.61. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.49 and a quick ratio of 1.87.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on EKSO. HC Wainwright dropped their price target on Ekso Bionics from $10.00 to $9.25 and set a “buy” rating for the company in a report on Tuesday, March 5th. StockNews.com raised Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.